This Perspective examines various aspects of the Great Healthcare Plan related to drug pricing, including over-the-counter expansion; subsidies, rebates, and cost sharing; and price transparency.
Robertson et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: